Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders
- 15 March 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 76 (11) , 960-967
Abstract
Objective: Neuronal nitric oxide synthase (nNOS), normally expressed at the sarcolemmal membrane, is known to be mislocalized to the sarcoplasm in several forms of muscular dystrophy. Our objectives were to characterize further the range of patients manifesting aberrant nNOS sarcolemmal immunolocalization and to study nNOS localization in animal models of nondystrophic myopathy. Methods: We carried out a retrospective cross-sectional study. We performed immunofluorescent staining for nNOS on biopsy specimens from 161 patients with acquired and nondystrophin inherited neuromuscular conditions. The localization of sarcolemmal nNOS correlated with mobility and functional status. Muscle specimens from mouse models of steroid-induced and starvation-related atrophy were studied for qualitative and quantitative nNOS expression. Results: Sarcolemmal nNOS staining was abnormal in 42% of patients with inherited myopathic conditions, 25% with acquired myopathic conditions, 57% with neurogenic conditions, and 93% with hypotonia. Interestingly, we found significant associations between mobility status or muscle function and sarcolemmal nNOS expression. Furthermore, mouse models of catabolic stress also demonstrated mislocalization of sarcolemmal nNOS. Conclusion: Our analyses indicate that nNOS mislocalization is observed in a broad range of nondystrophic neuromuscular conditions associated with impaired mobility status and catabolic stress. Our findings suggest that the assessment of sarcolemmal localization of nNOS represents an important tool for the evaluation of muscle biopsies of patients with a variety of inherited and acquired forms of neuromuscular disorders.Keywords
This publication has 22 references indexed in Scilit:
- Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscleJournal of Clinical Investigation, 2010
- DHPR α1S subunit controls skeletal muscle mass and morphogenesisThe EMBO Journal, 2009
- Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophyHuman Molecular Genetics, 2009
- Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophyJournal of Clinical Investigation, 2009
- Sarcolemma-localized nNOS is required to maintain activity after mild exerciseNature, 2008
- NOS isoform‐specific regulation of basal but not exercise‐induced mitochondrial biogenesis in mouse skeletal muscleThe Journal of Physiology, 2007
- NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOSJournal of Clinical Investigation, 2007
- Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular DystrophyPLOS ONE, 2007
- Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolismThe FASEB Journal, 2005
- Loss of sarcolemma nNOS in sarcoglycan‐deficient muscleThe FASEB Journal, 2002